RemAb Therapeutics at The Investment Readiness Series

RemAb Therapeutics was selected by Biocat to participate in “The Investment Readiness Series” in London, UK. On behalf of our Company, Dr. Bellowent to the Royal Society of Medicine where our CSO Daniel introduced the company to a panel of investors.

 

More infomation